SYVC — Synovics Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Synovics Pharmaceuticals, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2004 October 31st	C2005 October 31st	C2006 October 31st	C2007 October 31st	2008 October 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.629	0.129	2.39	0	0.066
Net Total Accounts Receivable
Net Total Receivables	0	0	2.04	3.33	3.82
Total Inventory
Prepaid Expenses
Total Current Assets	0.7	0.271	7.73	5.56	7.16
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.003	0.004	1.64	2.02	2.48
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2.87	16.9	38.9	23.3	22.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.78	5.61	13	25	13.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.78	5.61	25.8	31.4	17.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-0.905	11.3	13.1	-8.1	5
Total Liabilities & Shareholders' Equity	2.88	16.9	38.9	23.3	22.3
Total Common Shares Outstanding
Total Preferred Shares Outstanding